HLB Life Science Co., Ltd. (KOSDAQ:067630)

HLB Life Science Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 18, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	424,028	1,219,355	1,165,599	1,077,864	1,188,951	1,280,316
Market Cap Growth	-31.83%	4.61%	8.14%	-9.34%	-7.14%	-1.96%
Enterprise Value	535,769	1,270,943	1,260,366	1,030,778	1,020,209	1,153,412
Last Close Price	3480.00	10010.00	11155.39	10327.26	11533.40	12598.74
PE Ratio	-	198.66	-	-	-	-
PS Ratio	3.89	11.93	11.90	10.82	22.23	13.95
PB Ratio	1.35	3.06	5.04	4.57	4.82	4.45
P/TBV Ratio	1.66	3.45	6.66	7.52	6.48	6.10
P/OCF Ratio	-	-	-	-	-	636.96
EV/Sales Ratio	4.92	12.43	12.86	10.35	19.07	12.57
EV/FCF Ratio	-10.25	-	-	-	-	-
Debt / Equity Ratio	0.47	0.31	0.72	0.63	0.02	0.04
Asset Turnover	0.22	0.21	0.24	0.29	0.18	0.25
Inventory Turnover	20.58	18.44	12.26	16.27	30.72	19.42
Quick Ratio	0.85	1.86	0.68	5.50	11.28	9.85
Current Ratio	1.03	2.01	0.73	6.00	11.59	10.15
Return on Equity (ROE)	-23.14%	1.97%	-2.53%	-22.52%	-18.45%	-17.95%
Return on Assets (ROA)	-3.30%	-2.73%	-3.82%	-3.65%	-3.83%	-1.37%
Return on Capital (ROIC)	-3.42%	-2.86%	-4.08%	-3.93%	-4.16%	-1.55%
Earnings Yield	-18.32%	0.50%	-0.51%	-5.04%	-4.13%	-4.36%
FCF Yield	-12.32%	-4.86%	-2.63%	-3.75%	-1.39%	-0.50%
Buyback Yield / Dilution	-11.85%	-10.73%	-0.80%	-1.64%	-0.34%	-6.39%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.